This website uses cookies to ensure you have the best user experience. By continuing to use this website, you consent to our use of cookies. For more information, read our privacy policy.
This is a test.
Precision medicine for patients with co-existent ovarian and endometrial cancer: the COMPARE trial
This is a test.
Metabolic Gene-Edited CAR-T Cells For Ovarian Cancer Treatment
This is a test.
Metabolic engineering of CAR-T cells to overcome immune suppression
This is a test.
Remodeling the immune microenvironment of ovarian cancer using oncolytic viruses
This is a test.
Understanding how glycosylated antitumour ether lipids (GAELs) kill chemotherapy-resistant cancer cells
This is a test.
Investigating the “surfaceome” to discover new treatments for rare ovarian cancers
This is a test.
Understanding and targeting single-stranded DNA gap-filling mechanisms to improve chemotherapy response
This is a test.
Exploring a new therapeutic approach for rare ovarian cancers
This is a test.
Clonal hematopoiesis as a biomarker of poor prognosis in high-grade serous ovarian cancer
This is a test.
Enhancement of the University of Saskatchewan Gynecologic Oncology Biobank
